Your browser doesn't support javascript.
loading
Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamide.
Bivins, Vincent M; Durkin, Mike; Khilfeh, Ibrahim; Rossi, Carmine; Kinkead, Frederic; Waters, Dexter; Lefebvre, Patrick; Pilon, Dominic; Ellis, Lorie.
Affiliation
  • Bivins VM; Urology Centers of Alabama, Homewood, AL 35209, USA.
  • Durkin M; Former employee of Janssen Scientific Affairs, LLC, Horsham, PA 19044, USA.
  • Khilfeh I; Janssen Scientific Affairs, LLC, Horsham, PA 19044, USA.
  • Rossi C; Analysis Group, Inc., Montréal, QC H3B 0G7, Canada.
  • Kinkead F; Analysis Group, Inc., Montréal, QC H3B 0G7, Canada.
  • Waters D; Janssen Scientific Affairs, LLC, Horsham, PA 19044, USA.
  • Lefebvre P; Analysis Group, Inc., Montréal, QC H3B 0G7, Canada.
  • Pilon D; Analysis Group, Inc., Montréal, QC H3B 0G7, Canada.
  • Ellis L; Janssen Scientific Affairs, LLC, Horsham, PA 19044, USA.
Future Oncol ; 18(32): 3595-3607, 2022 Oct.
Article in En | MEDLINE | ID: mdl-36196743
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate-Specific Antigen / Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Journal: Future Oncol Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate-Specific Antigen / Prostatic Neoplasms, Castration-Resistant Limits: Humans / Male Language: En Journal: Future Oncol Year: 2022 Type: Article Affiliation country: United States